Legend Biotech (LEGN) News Today → Your Portfolio’s Shield Against Inflation: Gold’s Surge and AI Breakthroughs (From InvestorPlace) (Ad) Free LEGN Stock Alerts $43.20 -0.04 (-0.09%) (As of 02:34 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLegend Biotech Vaults on Quarterliesmsn.com - May 13 at 11:25 AMLegend Biotech Reports First Quarter 2024 Results and Recent Highlightsbusinesswire.com - May 13 at 7:00 AMJump Financial LLC Buys 74,272 Shares of Legend Biotech Co. (NASDAQ:LEGN)marketbeat.com - May 12 at 4:35 PMTimesSquare Capital Management LLC Increases Position in Legend Biotech Co. (NASDAQ:LEGN)marketbeat.com - May 9 at 8:30 PMLegend Biotech's (LEGN) Buy Rating Reiterated at HC Wainwrightmarketbeat.com - May 9 at 5:39 PMLegend Biotech (LEGN) Scheduled to Post Quarterly Earnings on Mondayamericanbankingnews.com - May 6 at 3:30 AMLegend Biotech Co. (NASDAQ:LEGN) Receives Average Recommendation of "Moderate Buy" from Analystsamericanbankingnews.com - May 4 at 3:48 AMLegend Biotech (NASDAQ:LEGN) Sets New 52-Week Low at $43.92marketbeat.com - April 30 at 6:48 PMLegend Biotech (NASDAQ:LEGN) Receives Buy Rating from HC Wainwrightmarketbeat.com - April 23 at 8:20 AMSumitomo Mitsui Trust Holdings Inc. Boosts Stake in Legend Biotech Co. (NASDAQ:LEGN)marketbeat.com - April 23 at 5:00 AMHold Rating on Legend Biotech Amidst Approval of Carvykti and Commercial Manufacturing Challengesmarkets.businessinsider.com - April 23 at 12:34 AMCARVYKTI® (ciltacabtagene autoleucel) Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple Myelomabusinesswire.com - April 22 at 1:05 PMLegend Biotech (NASDAQ:LEGN) Hits New 12-Month Low at $45.52marketbeat.com - April 22 at 12:00 PMFDA requires labeling changes to CAR-T cell therapies to reflect cancer riskmsn.com - April 20 at 6:09 PMMackenzie Financial Corp Has $9.19 Million Stock Position in Legend Biotech Co. (NASDAQ:LEGN)marketbeat.com - April 20 at 5:57 AMFederated Hermes Inc. Decreases Position in Legend Biotech Co. (NASDAQ:LEGN)marketbeat.com - April 19 at 8:27 AMQ3 2024 EPS Estimates for Legend Biotech Co. Lifted by HC Wainwright (NASDAQ:LEGN)marketbeat.com - April 18 at 6:16 AMScotiabank upgrades Legend Biotech to sector outperformseekingalpha.com - April 17 at 6:01 PMLegend Biotech Co. (NASDAQ:LEGN) to Post Q1 2024 Earnings of ($0.01) Per Share, HC Wainwright Forecastsmarketbeat.com - April 17 at 4:48 PMLegend Biotech (NASDAQ:LEGN) Raised to "Sector Outperform" at Scotiabankmarketbeat.com - April 17 at 3:50 PMLegend Biotech (NASDAQ:LEGN) Shares Gap Up to $50.12marketbeat.com - April 17 at 10:52 AMMirae Asset Global Investments Co. Ltd. Purchases New Stake in Legend Biotech Co. (NASDAQ:LEGN)marketbeat.com - April 17 at 4:51 AMBuy Rating Affirmed for Legend Biotech Amidst Anticipated Growth and Expanded Carvykti Usemarkets.businessinsider.com - April 17 at 1:56 AMBuy Rating Affirmed for Legend Biotech Amidst Growth Prospects and CARVYKTI’s Market Expansionmarkets.businessinsider.com - April 16 at 8:55 PMHC Wainwright Reaffirms "Buy" Rating for Legend Biotech (NASDAQ:LEGN)marketbeat.com - April 16 at 1:27 PMLegend Biotech (NASDAQ:LEGN) Sets New 1-Year Low at $49.13marketbeat.com - April 16 at 11:03 AMLEGN Quantitative Stock Analysisnasdaq.com - April 14 at 7:33 PMLegend Biotech is Now Oversold (LEGN)nasdaq.com - April 14 at 12:21 AMLegend Biotech to Host Investor Conference Call on First Quarter 2024 Resultsbusinesswire.com - April 11 at 8:00 AMQ2 2024 EPS Estimates for Legend Biotech Co. (NASDAQ:LEGN) Cut by HC Wainwrightmarketbeat.com - April 10 at 8:13 AMQ1 2024 Earnings Forecast for Legend Biotech Co. Issued By HC Wainwright (NASDAQ:LEGN)marketbeat.com - April 9 at 6:09 AMLegend Biotech Co. (NASDAQ:LEGN) Receives Consensus Recommendation of "Moderate Buy" from Analystsmarketbeat.com - April 9 at 4:41 AMAnalysts Offer Insights on Healthcare Companies: Pacira Pharmaceuticals (PCRX), Legend Biotech (LEGN) and Intellia Therapeutics (NTLA)markets.businessinsider.com - April 9 at 1:28 AMBuy Rating on Legend Biotech: FDA Approval and Market Potential Bolster Carvykti’s Outlookmarkets.businessinsider.com - April 7 at 6:54 PMLegend Biotech’s CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myelomafinance.yahoo.com - April 6 at 3:11 AMLegend Biotech's CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myelomabusinesswire.com - April 5 at 11:30 PMShould You Continue to Hold Legend Biotech Corporation (LEGN)?finance.yahoo.com - April 3 at 9:05 AMCantor Fitzgerald Begins Coverage on Legend Biotech (NASDAQ:LEGN)marketbeat.com - April 3 at 7:31 AMAnalysts Are Bullish on These Healthcare Stocks: Shockwave Medical (SWAV), Veeva Systems (VEEV)markets.businessinsider.com - April 2 at 12:57 PMNatera and Alliance for Clinical Trials in Oncology announce activation of mid-stage trial in urothelial cancerseekingalpha.com - April 1 at 4:55 PMLegend Biotech (NASDAQ:LEGN) Rating Reiterated by HC Wainwrightmarketbeat.com - April 1 at 8:30 AMStock market bubble warnings are everywhere. These are the 10 most richly valued stocks right now.msn.com - March 31 at 8:40 AMManagement’s Conservative Guidance Led Legend Biotech Corporation (LEGN) to Decline in Q4finance.yahoo.com - March 29 at 10:16 AMLegend Biotech (NASDAQ:LEGN) Stock Price Down 2.1%marketbeat.com - March 28 at 4:33 PMLegend Biotech Co. (NASDAQ:LEGN) is Matthews International Capital Management LLC's 5th Largest Positionmarketbeat.com - March 25 at 4:22 PMAnalysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Legend Biotech (LEGN)markets.businessinsider.com - March 24 at 10:10 AMDeutsche Bank AG Has $7.10 Million Holdings in Legend Biotech Co. (NASDAQ:LEGN)marketbeat.com - March 22 at 4:11 AMGenScript Losses Shrink On Strong Growth For Cancer Cell Therapybenzinga.com - March 20 at 7:36 PMLegend Biotech (NASDAQ:LEGN) Stock Price Down 5%marketbeat.com - March 19 at 3:09 PMLegend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Reportfinance.yahoo.com - March 19 at 1:03 PM Get Legend Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Your Portfolio’s Shield Against Inflation: Gold’s Surge and AI Breakthroughs (Ad)While gold may be thanking China for its recent growth, this sector is currently thanking Elon Musk. As crazy as it sounds, artificial intelligence just got one step closer to ushering in "the next step in human evolution"... and minting new millionaires. And it's all thanks to Musk's latest AI creation. Click to watch this device in action LEGN Media Mentions By Week LEGN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LEGN News Sentiment▼0.650.58▲Average Medical News Sentiment LEGN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LEGN Articles This Week▼84▲LEGN Articles Average Week Get Legend Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VKTX News ASND News CERE News ROIV News JAZZ News ITCI News CYTK News ELAN News BPMC News CTLT News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LEGN) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDoes this make you sick?Allegiance GoldBill Clinton Backing Biden Replacement???The Freeport SocietyUrgent Nvidia WarningAltimetryThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Legend Biotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
